Zurueck zur Suche

Reporte zur Charge UJ613AAA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

6Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
LA 2 MA 1 IL 1 NJ 1 IN 1

VAERS 2393342

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ613AAA

mild
Staat
MA
Alter
1,3
Geschlecht
F
Eingang
27.07.2022
Impfdatum
25.07.2022
Beginn
26.07.2022
Tage bis Beginn
1,0
Dosis
4
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Peripheral swelling Swelling Urticaria

Symptomtext

Hives in axillae, on torso, and inguinal. Redness and swelling of bellybutton. Left thigh swelling.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
TBD
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
Hx of egg allergy
Vorherige Impfungen
swelling at injection site left thigh following DTaP-HepB-IPV, HIB, PCV-13 given on 10/25/2021 (historical reporting)

VAERS 2605872

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ613AAA

gering
Staat
LA
Alter
1,4
Geschlecht
M
Eingang
29.03.2023
Impfdatum
21.03.2023
Beginn
21.03.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered No adverse event

Symptomtext

Patient administered expired vaccine. No adverse outcome reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2603677

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge UJ613AAA

gering
Staat
LA
Alter
1,0
Geschlecht
M
Eingang
24.03.2023
Impfdatum
21.03.2023
Beginn
21.03.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

an expired pentacel was given to a patient with no reported adverse event; Initial information received on 21-Mar-2023 regarding an unsolicited valid non-serious case received from an other health professional. This case involves a 1 years old male patient to whom an expired diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine [Pentacel (VERO)] was given with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included hepatitis A vaccine INACT (HAVRIX) for Prophylactic vaccination. On 21-Mar-2023, the patient received 0.25 ml (milliliter) of suspect diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine, suspension for injection(lot number: UJ613AAA, expiry date: 25-Feb-2023) (1x) (once) (With unknown strength) via intramuscular route in the right thigh for immunization. On 21-Mar-2023 the reporter reported that an expired pentacel was given to a patient with no reported adverse event (expired product administered) (latency: same day). No lab data were reported. Action taken: not applicable. At time of reporting, the outcome was Unknown for an event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2568328

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge UJ613AAA

gering
Staat
IL
Alter
0,2
Geschlecht
M
Eingang
26.01.2023
Impfdatum
05.01.2023
Beginn
05.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administration error

Symptomtext

medication error due to the DTaP/IPV component of PENTACEL being administered without the Hib component (with no reported adverse event); Initial information received on 17-Jan-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 2 month old male patient who had administered DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE [PENTACEL (VERO)] dtap/ipv component of pentacel without the hib component (with no reported adverse event). The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included HEPATITIS A VACCINE (HEPATITIS A); ROTAVIRUS VACCINE LIVE REASSORT ORAL 5V (ROTATEQ); and PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13) for Prophylactic vaccination. On 05-Jan-2023, the patient received 0.5 ml dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE for Suspension for injection (lot UJ613AAA, expiry date: 25-FEB-2023, strength not reported) via intramuscular route in the thigh nos for Immunization. On 05-JAN-2023 the patient was administered the dtap/ipv component of pentacel being without the hib component (with no reported adverse event) (product administration error) ( latency: same day). No lab data available. Action taken: not applicable. It was not reported if the patient received a corrective treatment for the event. At time of reporting, the outcome was Not Recovered / Not Resolved for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
HEPATITIS A; ROTATEQ; PREVNAR 13
Allergien
-
Vorherige Impfungen
-

VAERS 2537803

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge uj613aaa

gering
Staat
NJ
Alter
1,7
Geschlecht
M
Eingang
20.12.2022
Impfdatum
19.12.2022
Beginn
19.12.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Unevaluable event

Symptomtext

n/a

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
N/A
Vorgeschichte
L30.9
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2289154

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ613AAA

gering
Staat
IN
Alter
2,0
Geschlecht
M
Eingang
21.05.2022
Impfdatum
04.05.2022
Beginn
04.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

vaccines given post excursion with no reported adverse event; Initial information received on 06-May-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 2 years old male patient who experienced vaccines given post excursion with no reported adverse event while receiving vaccine diphtheria/tetanus/5 hybrid ac pertussis/ipv(mrc5)/hib(prp/t) vaccine [Pentacel]. The patient's past medical history, medical treatment(s), and family history were not provided. Concomitant medications included hepatitis a vaccine (Hepatitis A); measles vaccine, mumps vaccine, rubella vaccine (MMR) and varicella zoster vaccine (Varicella vaccine) for Immunisation. On 04-May-2022, the patient received a dose 0.5 ml once of suspect diphtheria/tetanus/5 hybrid ac pertussis/ipv(mrc5)/hib(prp/t) vaccine suspension for injection Strength: standard lot UJ613AAA via intramuscular route in the right thigh for Immunisation. On 04-MAY-2022 the patient was given vaccines post excursion with no reported adverse event (product storage error) Latency: same day. Action taken was not applicable. Outcome was Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-